CANCIDAS (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the CANCIDAS drug offered from Merck Sharp & Dohme Corp.. This Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
NON-PROPRIETARY NAME: | CASPOFUNGIN ACETATE |
SUBSTANCE NAME: | CASPOFUNGIN ACETATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2001-01-26 |
END MARKETING DATE: | 0000-00-00 |
CANCIDAS HUMAN PRESCRIPTION DRUG Details:
Item Description | CANCIDAS from Merck Sharp & Dohme Corp. |
LABELER NAME: | Merck Sharp & Dohme Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/mL) |
START MARKETING DATE: | 2001-01-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0006-3822_df4a2f99-0b41-4727-86ce-e50c18078089 |
PRODUCT NDC: | 0006-3822 |
APPLICATION NUMBER: | NDA021227 |
Other CASPOFUNGIN ACETATE Pharmaceutical Manufacturers / Labelers: